United States· US:50090-6143_a726ffd7-e7bd-4005-8b8a-b4d9bb58b67f

Atomoxetine

A atomoxetine product containing atomoxetine hydrochloride, registered in United States by A-S Medication Solutions. The same ATC class is registered in 17 of our 19 countries.

ATC N06BA09US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAtomoxetineATCN06BA09REGISTER NO.US:50090-6143_a726ffd…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Atomoxetine is registered in 17 of 19 countries.

Countries holding a registration under ATC N06BA09 (atomoxetine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Atomoxetine · ATC N06BA09

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of atomoxetine costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $1.05 in United States to $9.70 in Switzerland — a ×9.2 gap.

  • United States: $1.05 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Atomoxetine · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$9.70
  • ES Spain$2.37
  • US United States$1.05 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ATOMOXETINE HYDROCHLORIDE
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
N06BA09
ATC class
Atomoxetine
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5009061430
    30 CAPSULE in 1 BOTTLE (50090-6143-0)
  • ndc11
    50090-6143-0

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

275 interactions on record for atomoxetine.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Atomoxetine · interactions on record

275 records

  • 50 severe
  • 166 moderate
  • 4 minor
  • 54 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PapaverinC04AX38severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Atomoxetine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atomoxetine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Atofab, Atomoxetin Amarox
  • Belgium · Strattera
  • Bulgaria · Atofab
  • Cyprus · Strattera
  • Czechia · Atofab, Atominex
  • Germany · Agakalin, Atama
  • Denmark · Atomoxetin Amarox, Atomoxetin Glenmark
  • Estonia · Atominex
  • Spain · Atamax, Atomoxetina Aurovitas
  • Finland · Atomoxetin Orion, Atomoxetine Accord
  • United Kingdom (Northern Ireland) · Atomaid, Atomoxetine
  • Greece · Atama
  • Croatia · Attoxem
  • Hungary · Atomoxetin Amarox, Bitinex
  • Ireland · Atomoxetine Accord, Atomoxetine Azure
  • Iceland · Atomoxetin Actavis, Atomoxetin Medical Valley
  • Malta · Atomoxetina Generis, Atomoxetine Aurobindo
  • Netherlands · Atofab, Atomoxetine Accord
  • Norway · Atomoxetin Orion, Atomoxetine Accord
  • Poland · Atomoksetyna Medice, Auroxetyn
  • Portugal · Atomoxetina Generis, Atomoxetina Macleods
  • Romania · Atofab, Atomoxetin Accord
  • Sweden · Atomoxetin Actavis, Atomoxetin Amarox
  • Slovenia · Atomoksetin Accord, Strattera
  • Slovakia · Atofab, Atominex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8fa7a65-bc0b-4cb9-a872-3ccef6d86ee0
GET /v1/drugs/b8fa7a65-bc0b-4cb9-a872-3ccef6d86ee0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "40",
  "substance": "ATOMOXETINE HYDROCHLORIDE",
  "productndc": "50090-6143",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202682",
  "marketing_category": "ANDA"
}

See everything about atomoxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.